Design and evaluation of PROMIS® fatigue and cognitive function short forms customized for adults with primary sclerosing cholangitis
Donna M. Evon, Laura Mkumba, Nicole Lucas, Lin Li et autres
0 citationsQuality of Life Research
Christopher L. Bowlus
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
440Publications signalées
17595Citations signalées
3Affiliations récentes
Institutions déclarées
Domaines associés
Liver Diseases and ImmunityLiver Disease Diagnosis and TreatmentGallbladder and Bile Duct DisordersPediatric Hepatobiliary Diseases and TreatmentsDrug Transport and Resistance Mechanisms
Publications récentes
Symptom burden is associated with health-related quality of life in symptomatic adults with primary sclerosing cholangitis
Donna M. Evon, Kaya Merkler, Chelsea Anderson, Sasha Deutsch‐Link et autres
0 citationsHepatology Communications
Pruritus Is Frequent and Persistent and Impacts Quality of Life Among Patients With Primary Sclerosing Cholangitis
Richard Dean, Maryam Yazdanfar, Joseph Zepeda, Isha J. Patel et autres
0 citationsAlimentary Pharmacology & Therapeutics
Response to Commentary on “Impact of Disease‐Specific Treatment and NSBBs on Risk of PVT in Cirrhotic Patients With HCV or PBC ”
Humberto C. González, Stuart C. Gordon, Sheri Trudeau, Trueman Wu et autres
0 citationsLiver International
Fatigue and Cognitive Impairment in Adults With Primary Sclerosing Cholangitis: Results From Concept Elicitation Interviews
Donna M. Evon, Kaya Merkler, Laura Mkumba, Nicole Lucas et autres
1 citationLiver International
Elafibranor in primary biliary cholangitis: two-year placebo-controlled outcomes and long-term open-label data from the ELATIVE® phase III trial
Kris V. Kowdley, Christopher L. Bowlus, Cynthia Levy, Ulus Salih Akarca et autres
0 citationsJournal of Hepatology
Seladelpar in patients with primary biliary cholangitis and compensated cirrhosis: Efficacy and safety from RESPONSE and ASSURE studies
Stuart C. Gordon, Alejandra Villamil, Ira M. Jacobson, Eric Lawitz et autres
1 citationHepatology Communications
Impact of Disease‐Specific Treatment and Non‐Selective Beta Blockers on Risk of PVT in Cirrhotic Patients With HCV or PBC
Humberto C. González, Stuart C. Gordon, Sheri Trudeau, Trueman Wu et autres
2 citationsLiver International
138 - LONG-TERM TREATMENT WITH ELAFIBRANOR LEADS TO BIOCHEMICAL AND SYMPTOMATIC IMPROVEMENTS FOR AT LEAST 3 YEARS IN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS
Antonio Olveira, Cynthia Levy, Ulus Salih Akarca, Mario Reis Alvares-da-Silva et autres
0 citationsGastroenterología y Hepatología
143 - TREATMENT WITH ELAFIBRANOR LEADS TO STABILIZATION OF PRO-C3, A MARKER OF FIBROSIS, IN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS
Sergio Rodríguez-Tajes, Christopher L. Bowlus, Christophe Corpechot, Michael A. Heneghan et autres
0 citationsGastroenterología y Hepatología
146 - REDUCTION IN ITCH-ASSOCIATED DISABILITY AND PRURITUS DISTRIBUTION IN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS TREATED WITH SELADELPAR IN THE RESPONSE TRIAL
Andreas E. Kremer, David E.J. Jones, Marlyn J. Mayo, Christopher L. Bowlus et autres
0 citationsGastroenterología y Hepatología
Nebokitug, an Anti-chemokine (C-C Motif) Ligand 24 Monoclonal Antibody, in Patients With Primary Sclerosing Cholangitis: A Phase 2 Study
Christopher L. Bowlus, Douglas Thorburn, Stephen T. Barclay, Deepak Joshi et autres
2 citationsThe American Journal of Gastroenterology
BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.